Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Feb 1;227(3):402-406.
doi: 10.1093/infdis/jiac019.

Efficacy of a Carrageenan Gel in Increasing Clearance of Anal Human Papillomavirus Infections in Men: Interim Analysis of a Double-Blind, Randomized Controlled Trial

Cassandra Laurie  1 , Mariam El-Zein  1 , Joseph Tota  1 , Farzin Khosrow-Khavar  1 , Pierre-Paul Tellier  2 , François Coutlée  3 , Alexandra de Pokomandy  2   4 , Eduardo L Franco  1 ; Lubricant Investigation in Men to Inhibit Transmission of Human Papillomavirus Infection (LIMIT-HPV) Study Group
Collaborators, Affiliations
Randomized Controlled Trial

Efficacy of a Carrageenan Gel in Increasing Clearance of Anal Human Papillomavirus Infections in Men: Interim Analysis of a Double-Blind, Randomized Controlled Trial

Cassandra Laurie et al. J Infect Dis. .

Abstract

Preclinical studies have demonstrated carrageenan's anti-human papillomavirus (HPV) activity. We assessed efficacy of a carrageenan-based gel compared to a placebo gel in increasing the clearance of anal HPV infections among gay, bisexual, and other men who have sex with men (gbMSM). Of 255 enrolled gbMSM, 134 were HPV positive at baseline and had valid HPV results for ≥2 visits. Carrageenan did not differ from placebo in clearing all baseline infections (hazard ratio, 0.84 [95% confidence interval, .31-2.27]), based on having 2 consecutive HPV-negative visits following at least 1 HPV-positive visit. There were no remarkable differences for analyses at the HPV type level or by human immunodeficiency virus status.

Clinical trials registration: NCT02354144.

Keywords: HIV; HPV; and other men who have sex with men; bisexual; carrageenan; gay; gel; human papillomavirus; men who have sex with men; microbicide; randomized controlled trial.

PubMed Disclaimer

References

    1. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans: human papillomaviruses. 2007. https://monographs.iarc.fr/wp-content/uploads/2018/06/mono90.pdf. Accessed 23 October 2021.
    1. Daling JR, Madeleine MM, Johnson LG, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004; 101:270–80. - PubMed
    1. D’Souza G, Wiley DJ, Li X, et al. Incidence and epidemiology of anal cancer in the multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 2008; 48:491–9. - PMC - PubMed
    1. Machalek DA, Grulich AE, Jin F, Templeton DJ, Poynten IM.. The epidemiology and natural history of anal human papillomavirus infection in men who have sex with men. Sex Health 2012; 9:527–37. - PubMed
    1. Pokomandy A de, Rouleau D, Ghattas G, et al. Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG Cohort Study. J Infect Dis 2009; 199:965–73. - PubMed

Publication types

Associated data